|
|
PPXRD-3 - 23-25 February 2004!
HILTON HEAD ISLAND, South Carolina, USA
brought to you by the International Centre for Diffraction
Data
MAKE THE MOST OF YOUR XRPD DATA!
Secure fast development of drug candidates
Obtain reliable data for regulatory submissions
Provide the right data to support patent development
|
|
PPXRD Thanks the following sponsors:

|
|
PPXRD-3 Event Schedule
Monday, February 23
| Time |
Type |
Title of Paper |
Speaker & Affiliation |
| 8:30-9:00 |
|
WELCOMING REMARKS & INTRODUCTIONS |
John Faber, International Centre for Diffraction Data, Newtown Square, PA, USA |
| |
Acquisition and Use of X-ray Powder Diffraction Data Session Chair: Dr. Detlef Beckers, PANalytical, Almelo, The Netherlands
|
| 9:00-9:45
|
Invited
|
ACCURACY IN POWDER DIFFRACTION MEASUREMENTS
|
Robert L. Snyder, Georgia Institute of Technology, Atlanta, GA, USA
|
| 9:45-10:10
|
Contributed
|
IN-SITU VARIABLE TEMPERATURE POWDER X-RAY DIFFRACTION AND THERMAL ANALYSIS
|
Shawn Yin, Bristol-Myers Squibb Company, New Brunswick, NJ, USA
|
| 10:10-10:35
|
Contributed
|
GENERATION OF ACCURATE X-RAY POWDER DIFFRACTION DATA OF A PHARMACEUTICAL COMPOUND FOR INCLUSION INTO THE INTERNATIONAL CENTRE FOR DIFFRACTION DATA (ICDD) POWDER DIFFRACTION FILE (PDF)
|
Gerald Monger, GlaxoSmithKline, Research Triangle Park, NC, USA
|
| 10:35 - 11:05
|
Break
|
|
|
| 11:05-11:30
|
Contributed
|
FORMULATION ANALYSES OF OFF THE SHELF PHARMACEUTICALS
|
Timothy Fawcett, International Centre for Diffraction Data, Newtown Square, PA, USA
|
| 11:30-11:55
|
Contributed
|
RAPID COMBINATORIAL SCREENING BY TWO-DIMENSIONAL XRD
|
Bob He, Bruker AXS, Inc., Madison, WI, USA
|
| 11:55 - 1:25
|
Lunch
|
|
|
| Afternoon |
Con't: Acquisition and Use of X-ray Powder Diffraction Data Session Chair: Dr. Detlef Beckers, PANalytical, Almelo, The Netherlands
|
| Time |
Type |
Title of Paper |
Speaker & Affiliation |
| 1:50-2:15
|
Contributed
|
NEW DETECTOR TECHNOLOGY FOR SUPER SPEED X-RAY DIFFRACTION
|
Lutz Brügemann, Bruker AXS GmbH, Karlsruhe, Germany
|
| |
Powder Pattern Indexing and Pattern Matching Session Chair: Dr. Daniel Louër, University of Rennes, Rennes cedex, France
|
| 2:15 - 3:00
|
Invited
|
INDEXING: ALGORITHMS, ACCURACY, AND AB INITIO
|
James Kaduk, BP Chemicals, Naperville, IL, USA
|
| 3:00 - 3:30
|
Break
|
|
|
| 3:30 - 3:55
|
Contributed
|
ADVANCES IN INDEXING OF POWDER DIFFRACTION PATTERNS: ITERATIVE USE OF LEAST SQUARES AND MONTE-CARLO BASED WHOLE POWDER PATTERN DECOMPOSITION
|
Arnt Kern, Bruker AXS GmbH, Karlsruhe, Germany, speaking on behalf of Alan Coelho, Bruker AXS GmbH, Karlsruhe, Germany
|
| 3:55 - 4:20
|
Contributed
|
INDEXING POWDER DIFFRACTION PATTERNS WITH THE DICHOTOMY ALGORITHM
|
Daniel Louër, University of Rennes, Rennes cedex, France
|
| Evening (6:00-9:00)
Poster Session |
| Title of Paper |
Speaker & Affiliation |
| LAYERED STRUCTURE OF A MULTIPLE HYDRATE-FORMING PHARMACEUTICAL COMPOUND
|
Yuan-Hon Kiang, Merck & Co., Inc., West Point, PA, USA
|
| PREPARATION AND CHARACTERISATION OF GLIMEPIRIDE SOLID DISPERSIONS BY POWDER X-RAY DIFFRACTION AND DIFFERENTIAL SCANNING CALOROMETRY
|
Y.S.R. Krishnaiah, Kuwait University, Safat, Kuwait
|
| IN-SITU NANOSTRUCTURE MONITORING BY SMALL-AND WIDE-ANGLE X-RAY SCATTERING
|
Peter Laggner, IBR, and Hecus X-ray Systems, Graz, Graz, Austria
|
| DETERMINING THE RELATIVE SENSITIVITY OF X-RAY POWDER DIFFRACTION FOR IDENTIFYING AND MONITORING CRYSTAL FORM CHANGES OF ACTIVES IN SOLID DOSAGE FORMULATIONS
|
Gerald Monger, GlaxoSmithKline, Research Triangle Park, NC, USA
|
| ANALYSIS OF MANNITOL X-RAY DIFFRACTION PATTERNS
|
Fangling Needham, International Centre for Diffraction Data, Newtown Square, PA, USA
|
| AUTOMATIC PROCESSING AND PERFORMANCE QUALIFICATION (PQ) IN PHARMACEUTICAL APPLICATIONS
|
Jeffrey Nicolich, PANalytical, Natick, MA, USA
|
| SAXSess - AN ANALYTICAL TOOL FOR BIOMATERIALS
|
Heimo Schnablegger, Anton-Paar GmbH, Graz, Austria
|
| X-RAY POWDER DIFFRACTION AND SORPTION-DESORPTION INVESTIGATIONS OF INDAPAMIDE (WITHDRAWN)
|
Matej Smrkolj, Krka, d.d., Novo Mesto, Slovenia
|
| APPLICATION OF HIGH THROUGHPUT SCREENING TO THE STUDY OF THE CONFORMATIONAL POLYMORPHS OF “ROY”
|
Gregory Stephenson, Eli Lilly and Company, Indianapolis, IN, USA
|
| SINGLE CRYSTAL STUDIES OF MEFENAMIC ACID AS A TOOL TO UNDERSTAND POLYMORPHISM (WITHDRAWN)
|
Vrushali Waknis, National Institute of Pharmaceutical Education & Research (NIPER), Punjab, India
|
Tuesday, February 24
| Morning |
Structure Determination, Rietveld Refinement and Molecular Modeling Session Chair: Dr. Peter Stephens, State University of New York, Stony
Brook, NY, USA |
| Time |
Type |
Title of Paper |
Speaker & Affiliation |
| 8:30 - 9:15
|
Invited
|
IDENTIFICATION AND CRYSTAL STRUCTURE SOLUTION OF STABLE AND METASTABLE PHARMACEUTICAL COMPOUNDS USING X-RAY POWDER DIFFRACTION DATA
|
William David, CCLRC Rutherford Appleton Laboratory, Oxon, U.K.
|
| 9:15 - 10:00
|
Invited
|
CRYSTAL STRUCTURE SOLUTION AND REFINEMENT OF A SERIES OF D2/Β2 RECEPTOR AGONISTS USING LABORATORY X-RAY POWDER DIFFRACTION DATA
|
Kenneth Shankland, ISIS Facility Rutherford Appleton Laboratory, Oxon, U.K.
|
| 10:00 - 10:30
|
Break
|
|
|
| 10:30 - 10:55
|
Contributed
|
ANALYSIS OF SHORT RANGE ORDER IN X-RAY AMORPHOUS INDOMETHACIN USING X-RAY POWDER DIFFRACTION AND PAIR-WISE DISTRIBUTION FUNCTIONS
|
Simon Bates, SSCI, Inc., West Lafayette, Indiana, USA
|
| 10:55 - 11:20
|
Contributed
|
RECENT ADVANCES IN STRUCTURE SOLUTION FROM POWDER DIFFRACTION DATA
|
Cikui Liang, Accelrys, Inc., San Diego, CA, USA
|
| 11:20 - 11:45
|
Contributed
|
CRYSTAL STRUCTURE OF D-MANNITOL HEMIHYDRATE
|
Cristian Botez, Brookhaven National Laboratory and Stony Brook University, Upton, NY, USA
|
| 11:45 - 1:15
|
Lunch
|
|
|
| Afternoon |
Con't: Structure Determination, Rietveld Refinement and Molecular Modeling
|
| Time |
Type |
Title of Paper |
Speaker & Affiliation |
| 1:15 - 1:40
|
Contributed
|
STRUCTURE DETERMINATION OF AMBUIC ACID WITH SYNCHROTRON POWDER DIFFRACTION AND SOLID-STATE NMR
|
Yuegang Zhang, Argonne National Laboratory, Argonne, IL, USA
|
| 1:40-2:05
|
Contributed
|
THE CRYSTAL STRUCTURE OF GUAIFENESIN, 3-(2-METHOXYPHENOXY)-1,2-PROPANEDIOL
|
James Kaduk, BP Chemicals, Naperville, IL, USA
|
| |
Process Analytical Technology
Session Chair: Dr. Peter Varlashkin, GlaxoSmithKline, Research Triangle
Park, NC, USA
|
| 2:15-3:00
|
Invited
|
USE OF X-RAY POWDER DIFFRACTOMETRY TO MONITOR PHASE TRANSITIONS DURING PHARMACEUTICAL PROCESSING
|
Raj Suryanarayanan, University of Minnesota, Minneapolis, MN, USA
|
| 2:50 - 3:20
|
Break
|
|
|
| 3:20 - 3:45
|
Contributed
|
POLYCAPILLARY X-RAY OPTICS ENABLED DIFFRACTION-BASED PROCESS DIAGNOSTICS AND CONTROL
|
Simon Bates, SSCI, Inc., West Lafayette, IN, USA, speaking on behalf of Walter Gibson, X-ray Optical Systems, INC., East Greenbush, NY, USA
|
| 3:45-4:10
|
Contributed
|
IN SITU XRPD OF COMPACTS AS A POTENTIAL NON-DESTRUCTIVE ANALYTICAL TECHNIQUE FOR DETECTING PROCESS INDUCED PHASE CHANGES
|
Peter Wildfong, Purdue University, West Lafayette, IN, USA
|
| 4:10-4:35
|
Contributed
|
DEHYDRATION AND RE-HYDRATION OF TREHALOSE STUDIED BY HUMIDITY CONTROLLED SIMULTANEOUS MEASURING INSTRUMENT FOR X-RAY DIFFRACTOMETRY AND DIFFERENTIAL SCANNING CALORIMETRY(XRD-DSC)
|
Richard Ortega, Rigaku/MSC, Inc., The Woodlands, TX, USA
|
Wednesday, February 25
| Morning |
Polymorph Characterization by XRPD
Session Chair: Dr. Shawn Yin, Bristol-Myers Squibb, New Brunswick, NJ, USA |
| Time |
Type |
Title of Paper |
Speaker & Affiliation |
| 8:30-9:15
|
Invited
|
POLYMORPHS AND OTHER CRYSTAL FORMS: WHAT'S IN THAT POWDER?
|
Raymond Scaringe, Bristol-Myers Squibb, New Brunswick, NJ, USA
|
| 9:15-9:40
|
Contributed
|
PHARMACEUTICAL POWDER X-RAY DIFFRACTION: FROM DESIGN TO FINAL SELECTION OF A DEVELOPABLE MATERIAL
|
Julien Giovannini, AstraZeneca R&D, Scheelavagen, Lund, Sweden
|
| 9:40-10:05
|
Contributed
|
IDENTIFICATION OF POLYMORPH TYPE AND PREDICTION OF MATERIALS PROPERTIES FROM LABORATORY X-RAY POWDER PATTERNS USING INDEXING AND ELECTRON DENSITY CALCULATIONS
|
Igor Ivanisevic, SSCI, Inc., West Lafayette, Indiana, USA
|
| 10:05 - 10:35
|
Break
|
|
|
| 10:35-11:00
|
Contributed
|
POLYMORPHIC FORM SCREENING USING X-RAY POWDER DIFFRACTION
|
Gregory Stephenson, Eli Lilly and Company, Indianapolis, IN, USA
|
| 11:00 - 11:25
|
Contributed
|
INFLUENCE OF EXPERIMENTAL CONDITIONS ON THE PHASE TRANSITIONS OF Α, Α -TREHALOSE
|
Detlef Beckers, PANalytical B.V., Almelo, The Netherlands
|
| 11:25 - 12:55
|
Lunch
|
|
|
| Afternoon |
Regulatory and Patent Issues
Session Chair: Dr. Julien Giovannini, AstraZeneca R&D, Lund, Sweden |
| Time |
Type |
Title of Paper |
Speaker & Affiliation |
| 12:55-1:40
|
Invited
|
APPLICATIONS OF X-RAY POWDER DIFFRACTION TO REGULATORY ISSUES
|
Peter Wildfong, Purdue University, West Lafayette, IN, USA
|
| 1:40-2:25
|
Invited
|
PHARMACEUTICAL SOLID POLYMORPHISM – THE FDA VIEW
|
Andre Raw, FDA - Center for Drug Evaluation and Research, Rockville, MD, USA
|
| 2:25 - 2:50
|
Contributed
|
21CFR PART11 - WHAT'S LEFT (FOR XRPD)?
|
Arnt Kern, Bruker AXS GmbH, Karlsruhe, Germany
|
| 2:50 - 3:10
|
Break
|
|
|
| 3:10 - 3:55
|
Invited
|
POLYMORPHS AND PURITY AND PATENTS; OH MY.
|
Michael Teschner, Lerner, David, Littenberg, Krumholz & Mentlik, Westfield, NJ, USA
|
| 3:55 - 4:15
|
Q&A/Closing Remarks
|
|
|
|
. |